Fløtten, Øystein; Grønberg, Bjørn Henning; Bremnes, Roy M.; Amundsen, Tore; Sundstrøm, Stein Harald; Rolke, Heidi; HORNSLIEN, KJERSTI; Wentzel-Larsen, Tore; Aasebø, Ulf; von Plessen, Christian (Journal article; Tidsskriftartikkel; Peer reviewed, 2012-07-03)
BACKGROUND: Platinum-based doublet chemotherapy is the standard first-line treatment for advanced non-small cell lung cancer
(NSCLC), but earlier studies have suggested that non-platinum combinations are equally effective and better tolerated. We
conducted a national, randomised study to compare a non-platinum with a platinum combination.<p>
<p>METHODS: Eligible patients had stage IIIB/IV NSCLC ...